Preface; W. Vaalburg, Kong I. Lie. Foreword; E.E. van der Wall, P.K. Blanksma, M.G. Niemeyer, A.M.J. Paans. State of the art in cardiac positron emission tomography; P.G. Camici. Part One: Myocardial Viability. 1. Myocardial viability: stunning and hibernation; W. Flameng, B. Shivalkar, M. Borgers. 2. Positron emission tomography assessment of myocardial viability; Eng-Shiong Tan. 3. Comparison of thallium scintigraphy and positron emission tomography; M.G. Niemeyer, J.G. Meeder, A.F.M. Kuijper, P.K. Blanksma, E.E. van der Wall. 4. Cardiac metabolism: positron emission tomography versus single photon emission computed tomography; E.E. van der Wall. 5. The role of fluorine-19-deoxyglucose single photon emission computed tomography in predicting reversibility of regional wall motion abnormalities after revascularization; J.J. Bax, J.H. Cornel, F.C. Visser, P.M. Fioretti, A. van Lingen, J.M. Huitink, O. Kamp, G.J.J. Teule, C.A. Visser. 6. Parametric positron emission tomography imaging of myocardial perfusion and metabolism; A.T.M. Willemsen, P.K. Blanksma, A.M.J. Paans. 7. Positron emission tomography compared to single photo emission computed tomography in the evaluation of myocardial viability: a preliminary cost-effectiveness analysis; M.G.M. Hunink. 8. Assessment of myocardial viability by pharmacological stress echocardiography; J.H. Cornel, M.P. Fioretti. 9. Assessment of myocardial viability by magnetic resonance imaging techniques; C.A. Schneider, F. Baer, E. Voth, P. Theissen, U. Sechtem. Part Two: Hypertrophic Cardiomyopathy. 10. Classification of hypertrophic cardiomyopathy with magnetic resonance imaging compared with echocardiography; J.L. Posma, P.K. Blanksma, Kong I. Lie. 11. Positron emission tomography characterization of the myocardium in hypertrophic cardiomyopathy; P.K. Blanksma, J.L. Posma, R.M. de Jong, J. Pruim, A.T.M. Willemsen, R.L. Anthonio, E. van der Wall, W. Vaalburg, Kong I. Lie. 12. Treatment of hypertrophic obstructive cardiomyopathy with pacing; L. Kappenberger, X. Jeanrenaud, N. Aebischer. Part Three: Receptor Imaging Studies. 13. Heart failure and the cardiac beta-adrenoceptor; O.-E. Brodde. 14. Study of cardiac receptor ligands by positron emission tomography; A. van Waarde, P.H. Elsinga, R.L. Anthonio, T.J. Visser, P.K. Blanksma, G.M. Visser, A.M.J. Paans, W. Vaalburg. 15. Assessment of sympathetic cardiac innervation by scintigraphic techniques; G. Munch, Ngoc Nguyen, D. Wieland, M. Schwaiger. 16. Experimental and clinical cardiac beta-receptor studies; R.L. Anthonio, A. van Waarde, A.T.M. Willemsen, J. Pruim, W.H. van Gilst, P.K. Blanksma, W. Vaalburg, Kong I. Lie. Part Four: Myocardial Perfusion. 17. Methodological issues in regional myocardial perfusion imaging with positron emission tomography; A. Bol, W. Wijns, J.A. Melin. 18. Altered autonomic control of the cardiovascular system in syndrome X; J.G. Meeder. 19. Positron emission tomography studies of cardiac neurostimulation; R.W.M. Hautvast. Index.